Eric L. Keller

Director & CHIEF EXECUTIVE OFFICER

Director & CHIEF EXECUTIVE OFFICER at Retension Pharmaceuticals, Inc., filing insider transactions on 2026-10-13.

Total Purchases

$250K

1 transaction

Total Sales

—

0 transactions

Companies Traded

1 total filings

Active Since

2026-10-13

Last: 2026-10-13

Companies

Retension Pharmaceuticals, Inc.

Date	Ticker	Type	Shares	Price	Value	Owned After
2026-10-13	RTSN	Purchase	20.8K	$12.00	$250K	423.4K	SEC ↗